| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850732 | American Heart Journal | 2012 | 9 Pages |
Abstract
Up to a quarter of patients undergoing CABG will have a major cardiac event or repeat revascularization procedure within 5 years of surgery. Edifoligide does not affect outcomes after CABG; however, common identifiable baseline and procedural risk factors are associated with long-term outcomes after CABG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Renato D. MD, PhD, Judson B. MD, Rajendra H. MD, MS, Eric M. MS, Gail E. MS, Keith B. MD, Michael J. MD, Eric D. MD, MPH, Robert A. MD, C. Michael MD, Robert M. MD, Nicholas T. MD, T. Bruce MD, Todd J. MD, John H. MD, MHS,